Midwestern Regional Medical Center,Inc. DBA CTCA, Chicago ( Site 0003) — Zion, Illinois

Midwestern Regional Medical Center,Inc. DBA CTCA, Chicago ( Site 0003) is a clinical research site located in Zion, Illinois, United States 60099.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Midwestern Regional Medical Center,Inc. DBA CTCA, Chicago ( Site 0003) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Endometrial Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Zion

Browse all research sites in Illinois · View every site in Zion

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Midwestern Regional Medical Center,Inc. DBA CTCA, Chicago ( Site 0003)?

Midwestern Regional Medical Center,Inc. DBA CTCA, Chicago ( Site 0003) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Midwestern Regional Medical Center,Inc. DBA CTCA, Chicago ( Site 0003) conducted?

Midwestern Regional Medical Center,Inc. DBA CTCA, Chicago ( Site 0003) has 1 clinical trials on record, with 1 currently active. Their work covers Endometrial Neoplasms.

Is Midwestern Regional Medical Center,Inc. DBA CTCA, Chicago ( Site 0003) accredited by Crixeo Clinical Trials?

Midwestern Regional Medical Center,Inc. DBA CTCA, Chicago ( Site 0003) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Midwestern Regional Medical Center,Inc. DBA CTCA, Chicago ( Site 0003)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.